[DOI] [PubMed] [Google Scholar] [28].Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al
Cardiovascular safety clinical trials with arGLP1 in patients with type 2 diabetes mellitus
Additionally, Mounjaro , one of the newer diabetes drugs, which was approved in May 2022 and has a unique dual mechanism of action (it activates the GLP-1 hormone as well as another hormone called the glucose-dependent insulinotropic polypeptide or GIP, both helping to improve blood sugar) may be even more effective than semaglutide in reducing weight
Lisdexamfetamine is not metabolized by cytochrome P450 enzymes
Why You Need To Work With A Doctor When Youre On GLP-1 Medications Obesity is a complicated condition